Skip Nav Destination
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
Issue Archive
January 24 2023
Table of Contents
CLINICAL TRIALS AND OBSERVATIONS
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
Clinical Trials & Observations
Ibrahim Aldoss,Jun Yin,Anna Wall,Krzysztof Mrózek,Michaela Liedtke,David F. Claxton,Matthew C. Foster,Frederick R. Appelbaum,Harry P. Erba,Mark R. Litzow,Martin S. Tallman,Richard M. Stone,Richard A. Larson,Anjali S. Advani,Wendy Stock,Selina M. Luger
Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
Clinical Trials & Observations
The impact of in utero transfusions on perinatal outcomes in patients with alpha thalassemia major: the UCSF registry
Clinical Trials & Observations
Marisa E. Schwab,Billie R. Lianoglou,Dawn Gano,Juan Gonzalez Velez,Isabel E. Allen,Regina Arvon,Ahmet Baschat,Diana W. Bianchi,Melissa Bitanga,Anne Bourguignon,Richard N. Brown,Bruce Chen,May Chien,Shareece Davis-Nelson,Monique W. M. de Laat,Supachai Ekwattanakit,Yvonne Gollin,Greigh Hirata,Angie Jelin,Jennifer Jolley,Paul Meyer,Jena Miller,Mary E. Norton,Keith K. Ogasawara,Tachjaree Panchalee,Erica Schindewolf,Steven W. Shaw,Tammy Stumbaugh,Alexis A. Thompson,Dena Towner,Pai-Jong Stacy Tsai,Vip Viprakasit,Emmanuel Volanakis,Li Zhang,Elliott Vichinsky,Tippi C. MacKenzie
HEMATOPOIESIS AND STEM CELLS
LYMPHOID NEOPLASIA
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
Clinical Trials & Observations
Jakoba J. Eertink,Gerben J. C. Zwezerijnen,Sanne E. Wiegers,Simone Pieplenbosch,Martine E. D. Chamuleau,Pieternella J. Lugtenburg,Daphne de Jong,Bauke Ylstra,Matias Mendeville,Ulrich Dührsen,Christine Hanoun,Andreas Hüttmann,Julia Richter,Wolfram Klapper,Yvonne W. S. Jauw,Otto S. Hoekstra,Henrica C. W. de Vet,Ronald Boellaard,Josée M. Zijlstra,on behalf of the PETRA consortium
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma
Erica K. Barnell,Zachary L. Skidmore,Kenneth F. Newcomer,Monique Chavez,Katie M. Campbell,Kelsy C. Cotto,Nicholas C. Spies,Marianna B. Ruzinova,Tianjiao Wang,Brooj Abro,Friederike Kreisel,Bijal A. Parikh,Eric J. Duncavage,John L. Frater,Yi-Shan Lee,Anjum Hassan,Justin A. King,Daniel R. Kohnen,Mark A. Fiala,John S. Welch,Geoffrey L. Uy,Kiran Vij,Ravi Vij,Malachi Griffith,Obi L. Griffith,Lukas D. Wartman
TRANSPLANTATION
RESEARCH LETTERS
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia
Clinical Trials & Observations
Astrid Wintering,Kenichi Ishiyama,Stanley Tamaki,Courtney Tamaki,Joshua Fandel,Lingyun Ji,Brent L. Wood,Nirali N. Shah,Constance M. Yuan,Maureen M. O’Brien,Mignon L. Loh,Ernesto Diaz-Flores
COMMENTARY
RESPONSE
ERRATA
-
Cover Image
Cover Image
Surface rendering of a protein structure of platelet factor 4 (Protein Data Bank code 1RHP) showing the binding regions for antibodies developed in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT) after Ad26.COV2.S vaccination. The VITT binding site previously described is highlighted in red, and the amino acids of another possible antibody binding site are shown in blue. See the article by Huynh et al.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals